Psychemedics PMD micro-cap Due For Bullish Reversal Cycle
5% Dividend Yield, with 100% upside Share Potential
The world’s largest provider of hair testing for drugs of abuse
announced financial results for the first quarter ended March 31, 2023
And the declaration of a cash dividend of $0.07 per share to be paid on June 8, 2023, to shareholders of record as of May 25, 2023
The Company’s revenue for the quarter ended March 31, 2023, was $5.9 million versus $6.5 million for the quarter ended March 31, 2022, a decrease of 10%. Net loss for the quarter ended March 31, 2023, was $(384,000) or $(0.07) per diluted share, versus net income of $39,000 or $0.01 per diluted share, for the comparable period last year.
Psychemedics Corporation is a United States corporation which provides patented, FDA-cleared, CAP certified clinical laboratory services for the detection of drugs of abuse. The company's corporate headquarters are located in Acton, Massachusetts and its laboratory operations are located in Culver City, California. Wikipedia
Sciences
What Technological Progress?? ..."Across all fields of science and technology, we find that the rate of disruptive scientific work is declining."
comdig.unam.mx
The full paper;
arxiv.org
Here is a novel idea; Stop drinking the Coolaid!
The Seven Reason I Bought GILDI Bought GILD for seven reasons:
(1) Head and Shoulders Pattern (60 min)
(2) Horizontal Support from Left Shoulder ($102.72)
(3) 61.8% Fib level Support @ $102.75
(4) Descending Trend line Support
(5) Long-wicked Hammer found Support at Trend line
(6) Weekly Uptrend
(7) Selling Climax in February 2015
(8) The risk/reward potential is favorable. My reward is based on a daily and weekly chart. So, It is approx. $117.
-ScienceEvolution
